Phase 1B administration of COVID-19 vaccine

Iowa’s Infectious Disease Advisory Committee Recommendations for initial prioritization populations for Phase 1B administration of COVID-19 vaccine.

FINAL RECOMMENDATION 1/11/2021

The Iowa Infectious Disease Advisory Council (IDAC) has reviewed the priority population recommendations of Phase 1b identified in the Advisory Committee on Immunization Practices (ACIP) guidance issued December 20, 2020. IDAC offers the modifications and recommendations outlined below to assist vaccine providers in prioritizing Phase 1b populations. Upon activation of Phase 1b IDAC supports the continuation of vaccination efforts for individuals included in Phase 1A. IDAC will continue to discuss Phase 1C recommendations and expects to have an update this week. In addition, IDAC strongly supports that no individual shall be restricted from obtaining vaccine based on residency or citizenship as noted in the memo from the Iowa Department of Public Health Re: Administration of COVID-19 Vaccine – County/State of Residence, dated December 11, 2020. https://idph.iowa.gov/Portals/1/userfiles/61/covid19/vaccine/Vaccine%20M... The following factors shall be considered when sub-prioritizing Phase 1b populations recommended by IDAC (noted below), while a vaccine shortage exists: As local public health agencies and vaccine providers plan for limited use of vaccine among Phase 1B populations, the following factors shall be considered: 1. Historical COVID-19 disease trends affecting the eligible populations. 2. The risk of exposure, the risk of transmission, the risk of complications, the frequency of exposure, and the duration of exposure from COVID-19 for the eligible populations. Considerations should include congregate settings, workplace environmental controls, population density, and other factors that may impact risk of exposure and transmission of COVID-19. 3. Apply health equity considerations when prioritizing eligible populations. Considerations should include, but are not limited to access to health care, disparate health outcomes, socioeconomic status, insurance coverage, etc.